呋咯地辛
外觀
此條目可參照英語維基百科相應條目來擴充。 (2024年11月9日) |
臨床資料 | |
---|---|
商品名 | Mundesine and Fodosine |
給藥途徑 | oral |
識別資訊 | |
| |
CAS號 | 209799-67-7 |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C11H14N4O4 |
摩爾質量 | 266.26 g·mol−1 |
3D模型(JSmol) | |
| |
|
呋咯地辛(INN:Forodesine,也稱為Immucillin H,商品名有:Mundesine、Fodosine等)是一種有機化合物,分子式C11H14N4O4,屬於嘌呤核苷類似物,用於治療T細胞急性淋巴母細胞性白血病(T-ALL)和B細胞急性淋巴母細胞性白血病(B-ALL)[1]。
參考文獻
[編輯]- ^ Kicska GA, Long L, Hörig H, Fairchild C, Tyler PC, Furneaux RH, et al. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. April 2001, 98 (8): 4593–4598. Bibcode:2001PNAS...98.4593K. PMC 31879 . PMID 11287638. doi:10.1073/pnas.071050798 .
外部連結
[編輯]- From cell biology to therapy: forodesine. Hematology Meeting Reports. 2008, 2 (5): 106–111.
- Gore L, Stelljes M, Quinones R. Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?. Seminars in Oncology. December 2007, 34 (6 Suppl 5): S35–S39. PMID 18086346. doi:10.1053/j.seminoncol.2007.11.005.
- 18 December 2006 Fodosine orphan designation by the European Commission for acute lymphoblastic leukaemia.